Home

Norethisterone enanthate

Norethisterone enanthate

Specifications

3836-23-5CAS Number
223-326-7EC Number
[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoateIUPAC Name
C27H38O3Chemical Formula
410.6 g/molMolecular Weight
Norethisterone enanthate; 3836-23-5; NORETHINDRONE ENANTHATE; Norethisterone enantate; Norigest; Norethisterone oenanthate; HY3S2K0J0F; NSC-22846; ZK-5410; 17alpha-Ethynyl-17beta-heptanoyloxy-4-estren-3-one; SH-8.0393; 19-Norpregn-4-en-20-yn-3-one, 17-((1-oxoheptyl)oxy)-, (17alpha)-; 19-norethindrone enanthate; RefChem:166601; (17 alpha)-17-((1-oxoheptyl)oxy)-19-norpregn-4-en-20-yn-3-one; (1R,3aS,3bR,9aR,9bS,11aS)-1-ethynyl-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-1-yl heptanoate; 223-326-7; Noristerat; Norlutin enanthate; DTXSID2048664; [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate; MFCD01741291; SH 393; NEE; 19-Norpregn-4-en-20-yn-3-one, 17-[(1-oxoheptyl)oxy]-, (17a)-; Sovel; UNII-HY3S2K0J0F; CCRIS 6526; 17alpha-Ethynyl-19-nortestosterone enanthate; APTGJECXMIKIET-WOSSHHRXSA-N; Noristerat (TN); NCGC00182712-01; 17alpha-Ethynyl-19-nortestosterone 17-heptanoate; EINECS 223-326-7; LG 202; BRN 3176529; norethindrone heptanoate; norethisterone-enanthate; 17alpha-Ethinyl-19-nortestosterone enanthate; 17-alpha-Ethinyl-19-nortestosterone enanthate; SCHEMBL354296; 17-alpha-Ethynyl-17-beta-heptanoyloxy-4-estren-3-one; orb1306555; 17-beta-Heptanoyloxy-17-alpha-ethynyl-4-oestren-3-one; 19-nor-17alpha-Pregnen-20-ynone, 17beta-heptanoyloxy-; CHEMBL3187229; DTXCID9028590; CHEBI:34894; 3-oxo-19-nor-17alpha-pregn-4-en-20-in-17-yl-heptanot; HY-A0285; Norethindrone enanthate;Norethisterone heptanoate; Norigest; Noristerat; SH 8.0393; ZK 5410; NSC22846; Tox21_113027; 19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, heptanate; s6589; AKOS015896289; AC-6835; DB14678; NORETHISTERONE ENANTATE [MART.]; NORETHISTERONE ENANTATE [WHO-DD]; NORETHISTERONE ENANTATE [WHO-IP]; AS-13385; SY465807; CAS-3836-23-5; CS-0019768; NORETHISTERONI ENANTAS [WHO-IP LATIN]; NS00030374; 17.alpha.-Ethinyl-19-nortestosterone enanthate; 17.alpha.-Ethynyl-19-nortestosterone enanthate; D08285; G13056; T20720; Norethisterone Enantate (Norethindrone Enanthate); 17.alpha.-Ethynyl-19-nortestosterone 17-heptanoate; Q7050956; WLN: L E5 B666 OV MUTJ E1 FOV6 F1UU1; BRD-K07625016-001-01-2; 19-Nor-17.alpha.-pregn-4-en-20-yn-3-one, heptanate; 19-Nor-17.alpha.-pregn-4-en-20-yn-3-one, heptanoate; 17.alpha.-Ethynyl-17.beta.-heptanoyloxy-4-estren-3-one; 19-Nor-17-alpha-pregnen-20-ynone, 17-beta-heptanoyloxy-; 3-Oxo-17alpha-19-norpregn-4-en-20-yn-17-yl heptanoate; 19-nor-17.alpha.-Pregnen-20-ynone, 17.beta.-heptanoyloxy-; (17alpha)-17-((1-Oxoheptyl)oxy)-19-norpregn-4-en-20-yn-3-one; 19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, heptanoate; 19-NORPREGN-4-EN-20-YN-3-ONE, 17-((1-OXOHEPTYL)OXY)-, (17.ALPHA.)-; (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoateSynonyms